109 Episoder

1. ASCO GU24 special: Prof. Christophe Hennequin on GETUG-AFU 18 trial results

   Udgivet: 25.2.2024
2. Special series on RCC: Role of cytoreductive nephrectomy for mRCC with Assist. Prof. Mari and Prof. Badani

   Udgivet: 18.2.2024
3. ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptide

   Udgivet: 14.2.2024
4. ASCO GU24 special: Prof. Nizar Tannir shares CheckMate 214 results

   Udgivet: 11.2.2024
5. ASCO GU24 special: Dr. Kim Chi discusses CONTACT-2 results

   Udgivet: 7.2.2024
6. ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914

   Udgivet: 4.2.2024
7. ASCO GU24 special: Dr. Andrea Apolo shares AMBASSADOR results

   Udgivet: 31.1.2024
8. Dr. Srikala Sridhar talks about PET imaging on staging of MIBC

   Udgivet: 14.1.2024
9. Dr. Nic an Riogh discusses bladder outlet obstruction in women

   Udgivet: 10.1.2024
10. UROONCO RCC take home message for 2023

    Udgivet: 27.12.2023
11. Special series: Assoc. Prof. Şener and Dr. Pietropaolo talk about networking and building professional relationships in urology

    Udgivet: 17.12.2023
12. Special series: Dr. Seguí-Moya talks with Prof. Brookman-May about preparing for a job interview

    Udgivet: 10.12.2023
13. Special series: Dr. Rai and Dr. Kamphuis talk about preparing and keeping your CV updated

    Udgivet: 2.12.2023
14. Special series: Ms. Moreno-Fontela and Assoc. Prof. Kasivisvanathan discuss the significant transition after residency

    Udgivet: 25.11.2023
15. Prof. James Catto (GB) shares results of THOR-2 cohort 1 study

    Udgivet: 12.11.2023
16. Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg

    Udgivet: 8.11.2023
17. Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatment

    Udgivet: 1.11.2023
18. Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patients

    Udgivet: 28.10.2023
19. ESMO 2023 special: Dr. Van Der Heijden talks about the phase 3 CheckMate 901 trial results

    Udgivet: 24.10.2023
20. ESMO 2023 special: Prof. Powles shares positive KEYNOTE-A39 trial results

    Udgivet: 22.10.2023